Prevalence of various urological disorders has led to an upsurge in adoption of the urology devices globally. For instance, according to the American Urological Association Foundation (AUAF), benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections (UTIS), and kidney and ureteral stones are among the most common urological diseases. Moreover, as per the United States Department of Health and Human Services, the overall prevalence of CKD among the American population is about 14%, and almost half of the individuals with CKD suffer from diabetes and/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis.
Urinary tract infections (UTIs) are one of the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with it. With a global increase in diabetic population, complications, like dysuria and organ damage are associated with UTIs, that are also on the rise.
Based on product, the global Urology Devices market is segmented into instruments and consumables & accessories. Currently, instruments segment dominated the market and is expected to maintain its dominance during the forecast period owing to the technological advancements coupled with the launch of new and advanced urology instruments.
Based on diseases, the market is divided into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other diseases. Kidney diseases dominated the market in 2020 owing to the growing patient pool of chronic kidney disease due to the rising geriatric population.
Based on end-users, the market is segmented into hospitals and clinics, dialysis centers and others. Currently hospitals dominates the market and is expected to maintain its dominance during the analyzed period owing to the rising number of hospitals and infrastructural & economic development, especially in emerging countries.
For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for Urology Devices on account of increasing prevalence of chronic and lifestyle conditions, increasing healthcare spending, highly developed healthcare system in the US and Canada, and presence of a better reimbursement structure.
Some of the major players operating in the market includes Baxter, Boston Scientific, C. R. Bard, Medtronic, Siemens, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, and Sanofi; etc.